• Most Popular
  • Most Shared

UPDATE 1-Basilea says superbug drug gets positive opinion

Fri Nov 21, 2008 2:01am EST

Stocks

   

(Refiles to remove extraneous text in second paragraph)

Adds more details)

ZURICH, Nov 21 (Reuters) - Basilea Pharmaceutica's (BSLN.S) MRSA superbug antibiotic ceftobiprole has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of complicated skin and soft tissue infections, the Swiss biotech company said on Friday.

The drug will be marketed under the Zevtera trade name in Europe.

Recommendations for marketing approval by the CHMP are usually endorsed by the European Commission within a couple of months.

Earlier this month ceftobiprole -- co-developed with Johnson & Johnson's (JNJ.N) Janssen-Cilag unit -- received approval in Switzerland for the treatment of complicated skin and soft tissue infections including diabetic foot infections. (Reporting by Katie Reid; Editing by Greg Mahlich)



More from Reuters

Photo

Honda expands airbag recall as more Toyotas probed

TOKYO/DETROIT (Reuters) - Honda Motor Co said it would recall another 440,000 cars around the world for faulty airbags as rival Toyota Motor Corp faced further probes over its largest-ever safety crisis. | Video

» More Top News
A worker walks on steel frames at a construction site in central Beijing January 27, 2010. REUTERS/Loic Hofstedt
Analysis:

China's boom may lead to bust

The housing market is becoming the investment of choice for the Chinese, which is making policymakers very nervous.  Full Article 

China
A Greek flag at the Bank of Greece is seen near a statue of ancient philosopher Socrates in Athens February 5, 2010. REUTERS/Yiorgos Karahalis

Avoiding "another Greece"

Don't count on the euro zone growing anytime soon. Getting into the single-currency club will be tougher than ever.  Full Article 

Global Markets